0599 (Imatinib Mesylate 400 mg)

Pill with imprint 0599 is Brown, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 0599

Imatinib Mesylate

Imprint

0599

Strength

400 mg

Color

Brown

Shape

Capsule-shape

Availability

Prescription only

Drug Class

BCR-ABL tyrosine kinase inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Breckenridge Pharmaceutical, Inc.

Manufacturer

Stason Pharmaceuticals, Inc.

National Drug Code (NDC)

51991-0377

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "0599"

Etodolac

Etodolac

Cefadroxil Monohydate

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer